Ind Swift Ltd
INDSWFTLTDInd Swift Ltd
INDSWFTLTD
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 2.66 | -0.22 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.23 | 6.64 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ind-Swift Limited is a manufacture of formulations. The Company is a pharmaceutical company, which offers finished goods dosage, active pharmaceutical ingredients (APIs) and herbal products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Mankind Pharma Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 421.99 | 483.39 | 560.24 | 581.75 | ||||
Raw Materials | 212.44 | 233.47 | 251.33 | 451.39 | ||||
| Power & Fuel Cost | 10.62 | 10.96 | 12.39 | |||||
| Employee Cost | 57.75 | 63.75 | 72.92 | |||||
| Selling & Administrative Expenses | 33.72 | 62.41 | 67.87 | |||||
| Operating & Other expenses | 37.84 | -1.67 | 49.23 | |||||
EBITDA | 69.62 | 114.47 | 106.50 | 130.36 | ||||
| Depreciation/Amortization | 32.07 | 28.67 | 27.11 | 24.42 | ||||
| PBIT | 37.55 | 85.80 | 79.39 | 105.94 | ||||
| Interest & Other Items | 57.16 | 59.76 | 62.94 | 48.80 | ||||
| PBT | -19.61 | 26.04 | 16.45 | 57.14 | ||||
| Taxes & Other Items | 0.42 | 0.00 | 2.23 | 2.23 | ||||
| Net Income | -20.03 | 26.04 | 14.22 | 54.91 | ||||
| EPS | -3.70 | 4.81 | 2.63 | 10.14 | ||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ind Swift Ltd | 10.26 | -0.22 | — |
| Sun Pharmaceutical Industries Ltd | 45.62 | 6.51 | 0.74% |
| Mankind Pharma Ltd | 62.83 | 12.55 | — |
| Cipla Ltd | 28.94 | 4.45 | 0.88% |
Price Comparison
Compare INDSWFTLTD with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INDSWFTLTD has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 21, 2011
Dividend/Share
₹0.40
Ex DateEx Date
Sep 21, 2011
Cash Dividend
Ex DateEx DateSep 24, 2010
Dividend/Share
₹0.40
Ex DateEx Date
Sep 24, 2010
Net profit of Ind-Swift reported to Rs 4.11 crore in the quarter ended September 2024 as against net loss of Rs 10.71 crore during the previous quarter ended September 2023. Sales rose 17.62% to Rs 136.35 crore in the quarter ended September 2024 as against Rs 115.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales136.35115.92 18 OPM %10.569.61 - PBDT9.51-3.97 LP PBT4.11-10.71 LP NP4.11-10.71 LP Powered by Capital Market - Live
Ind-Swift will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Ind-Swift rose 1096.61% to Rs 28.24 crore in the quarter ended June 2024 as against Rs 2.36 crore during the previous quarter ended June 2023. Sales declined 23.35% to Rs 113.85 crore in the quarter ended June 2024 as against Rs 148.54 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales113.85148.54 -23 OPM %2.8312.39 - PBDT33.619.08 270 PBT28.242.36 1097 NP28.242.36 1097 Powered by Capital Market - Live
Ind-Swift will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Stocks that will see action today (November 2)
Ind Swift Labs tanks 16% on selling API business to PI Industries
BRIEF-Ind Swift Ltd Reports Sept-Qtr Loss - Investing.com India
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant